The approval comes a day after Sinopharm said its vaccine showed 79.34 per cent efficacy and a 99.52 per cent antibody-positive conversion rate in the interim results of the Phase III clinical trials.
The global health intelligence company had said China's zero-COVID strategy also means the population has almost no naturally acquired immunity through the previous infection.
A notice issued to the foreign journalists on Wednesday said they can get the Inactivated SARS-CoV-2 Vaccine, developed by Sinopharm's China National Biotec Group. Sinopharm's COVID-19 vaccine has been granted conditional market approval by China's National Medical Products Administration.
The Wold Health Organisation has granted approval on June 1 to China's second COVID-19 vaccine, Sinovac, which was expected to strengthen China's vaccine diplomacy.
The move follows the World Health Organisation's Emergency Use Listing for Covaxin, which is the second most used formulation in India.
Australia's medicines and medical devices regulator on Monday formally recognised India's Covaxin, a vaccine against the coronavirus as the country's border was reopened for the first time in nearly 20 months.
China has given conditional approval for a single dose COVID-19 vaccine, touted to be a rival to Johnson & Johnson's one-jab shot cleared by the United States drug regulator on Sunday.
'Viral infections rise in winter and better care needs to be taken in the next few months.'
A technical advisory group of the World Health Organisation was on Tuesday reviewing data on Covaxin for the emergency use listing of India's indigenously-made vaccine and it could pronounce its decision within the next 24 hours or so, a spokesperson said.
A technical advisory group of the UN health agency which met on Tuesday has sought "additional clarifications" from Bharat Biotech for Covaxin to conduct a final "risk-benefit assessment" for Emergency Use Listing of the vaccine.
The distribution of the Covid-19 vaccine is underway across the world. To provide a convenient and safe place for people to receive COVID-19 vaccines, countries around the world transform shopping malls, churches, airports, subway stations and museums to vaccination centers. Some also offer vaccination services on the river and mountain.
The technical advisory group will now meet on November 3 for a final assessment.
Snooping is one of the oldest peccadilloes of man, observes Ambassador M K Bhadrakumar.
Addressing a press briefing, Union Health Secretary Rajesh Bhushan said Zydus Cadila, Sputnik V, Biological E and Gennova are other vaccines also in the pipeline which are in advanced clinical trials in India.
HDFC was the leading gainer among Sensex stocks on Thursday, rising by 1.65 per cent, followed by Sun Pharma, ICICI Bank, Asian Paints, Titan and Infosys. TCS was the biggest loser, shedding 1.33 per cent. Ultratech Cement, Bharti Airtel, Kotak Bank and Tech Mahindra were among the other major laggards.
'I took a Chinese vaccine named Sinopharm and I want people to know it is absolutely safe. I was administered the first dose on January 6. I have to go back for a second dose on January 27.'
Experts, however, feel that given the intensity of the second wave and the high single dose coverage, India is in a good position to avoid any drastic wave in the near future.
Over 200 world leaders, including former presidents, prime ministers and ministers have backed a campaign urging the Group of Seven (G7) rich nations to help vaccinate the world's poorest from low-income economies against COVID-19 by paying two-thirds of an estimated $66 billion required.
Core to the planning is the rigidly-enforced closed loop that physically separates Games-related personnel from the local population
There is a process to be followed for EUL and pre-qualification of vaccines under which a company has to complete phase 3 trials and submit the whole data to the regulatory department of WHO which is examined by an expert advisory group," Swaminathan said.
Khan's spokesman Dr Shehbaz Gill said that the prime minister has just a slight fever and cough.
Scientists around the world, including in India, suggest it hasn't been tested properly given the time constraint and there may not be enough evidence to prove its efficacy.
As India prepares to launch its vaccine drive on January 16, here is a look at the options:
'All the vaccines that are available in most countries, right now, are all highly effective and safe.'
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances